(NYSE: AORT) Artivion's forecast annual revenue growth rate of 9.38% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.88%.
Artivion's revenue in 2026 is $471,474,000.On average, 10 Wall Street analysts forecast AORT's revenue for 2026 to be $24,386,886,620, with the lowest AORT revenue forecast at $22,934,926,358, and the highest AORT revenue forecast at $25,341,045,865. On average, 10 Wall Street analysts forecast AORT's revenue for 2027 to be $27,013,384,245, with the lowest AORT revenue forecast at $25,070,936,400, and the highest AORT revenue forecast at $28,566,269,884.
In 2028, AORT is forecast to generate $30,225,444,085 in revenue, with the lowest revenue forecast at $28,415,613,161 and the highest revenue forecast at $31,633,036,185.